1. Home
  2. UBER vs NVO Comparison

UBER vs NVO Comparison

Compare UBER & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uber Technologies Inc.

UBER

Uber Technologies Inc.

HOLD

Current Price

$77.46

Market Cap

150.9B

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$40.42

Market Cap

166.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBER
NVO
Founded
2009
1923
Country
United States
Denmark
Employees
N/A
69500
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.9B
166.1B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
UBER
NVO
Price
$77.46
$40.42
Analyst Decision
Strong Buy
Hold
Analyst Count
33
11
Target Price
$107.03
$51.00
AVG Volume (30 Days)
12.3M
13.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
3.17%
EPS Growth
3.73
N/A
EPS
4.73
N/A
Revenue
$52,017,000,000.00
N/A
Revenue This Year
$14.40
N/A
Revenue Next Year
$14.27
$3.88
P/E Ratio
$16.26
$13.60
Revenue Growth
18.28
N/A
52 Week Low
$68.46
$35.12
52 Week High
$101.99
$81.44

Technical Indicators

Market Signals
Indicator
UBER
NVO
Relative Strength Index (RSI) 61.50 59.23
Support Level $69.10 $35.49
Resistance Level $78.74 $50.30
Average True Range (ATR) 2.27 1.02
MACD 0.81 0.74
Stochastic Oscillator 86.91 84.15

Price Performance

Historical Comparison
UBER
NVO

About UBER Uber Technologies Inc.

Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 202 million users who order rides or food at least once a month.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: